Nexturn Bioscience Co., Ltd. logo

Nexturn Bioscience Co., Ltd. (089140)

Market Closed
11 Aug, 06:30
KRX SM KRX SM
2,390. 00
+70
+3.0172%
40.48B Market Cap
- P/E Ratio
400% Div Yield
42,041 Volume
- Eps
2,320
Previous Close
Add Transaction
Day Range
2,270 2,390
Year Range
1,853 3,250
Want to track 089140 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Nexturn Bioscience Co., Ltd. (089140) Statistics

Valuation metrics

Market Cap 40.48B
Enterprise value 117.13B
Trailing P/E (ttm) -1.73
Forward P/E -
PEG ratio 0.02
Price/Sales (ttm) 0.57
Price/Book (mrq) 0.12
Enterprise Value/Revenue 1.66
Enterprise Value/EBITDA 28.33

Overview

Shares outstanding 10.43M
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 444.81K
Average volume (90 days) 178.58K

Price summary

52-Week low 1,853
52-Week high 3,250
Beta -
50-Day moving average 2,182.3
200-Day moving average 2,330.2

Dividends and splits

Forward annual dividend rate 400
Forward annual dividend yield 0.1473%
Trailing annual dividend rate 100
Trailing annual dividend yield 0.0368%
5-Year annual dividend yield -
Payout ratio -
Dividend Date 5 Jan 2021
Ex-Dividend Date 29 Dec 2020
Last split factor 1:5
Last split Date 4 May 2023

Financials

Fiscal year

Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026

Profitability

Profit margin 0.29%
Operating margin -0.01%

Operational effectiveness

Return on assets -0.03%
Return on equity -0.04%

Income Statement

Revenue (ttm) 70.44B
Revenue per share (ttm) 2,894.43
Quarterly revenue growth (yoy) 0.17%
Gross profit (ttm) 20.46B
EBITDA 4.13B
Net income to common (ttm) -9.69B
Diluted EPS (ttm) -1,190
Quarterly earnings growth (yoy) 2.98%

Balance Sheet

Total cash (mrq) 4.57M
Total cash per share (mrq) 0.38
Total debt (mrq) 96.65B
Total Debt/Equity (mrq) 0.43
Current ratio (mrq) 0.86%
Book value per share (mrq) 16,865.31

Cash Flow

Cash flow statement -42.95B
Levered free cash flow (LFCF) -9.69B